Announcement
27 Dec 2023
In December 2023, the U.S. Administration determined that essential medicines, medical countermeasures, and critical inputs are eligible for certain subsidies and public procurement advantages under DPA Title III Section 303.
Source
Sign in to access
Number of interventions
3
3 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
27 Dec 2023
Revocation date:
No revocation date
Updated: 27 Dec 2023
In-kind grant
In force
On 27 December 2023, the U.S. Administration activated certain incentives for essential medicines, medical countermeasures, and critical inputs following designating the subject products under the ...
Sign in to see more
Updated: 27 Dec 2023
State aid, unspecified
In force
On 27 December 2023, the U.S. Administration issued an authorization determining essential medicines, medical countermeasures, and critical inputs as eligible to receive unspecified subsidy payment...
Sign in to see more
Updated: 27 Dec 2023
Public procurement, nes
In force
On 27 December 2023, the U.S. Administration activated certain incentives for the essential medicines, medical countermeasures, and critical inputs following designating the subject products under ...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.